NCT06894810

Brief Summary

The current standard of care for paediatric patients with cancer regarding preservation of their fertility (FP) is to provide high-quality information during the clinical consultation process. However, this approach depends on health provider knowledge and communication and has been shown to be sub-optimal in some situations. This impairs the critical decision-making of patients regarding fertility testing, utilization of gametes, and continuing payment of storage fees. The fertility preservation decision aid (FP DA) may lead to a greater understanding of their fertility status for participants. This knowledge may allow participants the opportunity to assess potential fertility issues prior to the end of their reproductive window, helping to minimize missed opportunities for parenthood. This research study aims to assess the effectiveness of the use of the FP DA on unmet fertility information needs when it is provided in addition to high-quality information in parents of cancer survivors and CAYA cancer survivors compared to high-quality information alone.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
358

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Dec 2025Jul 2026

First Submitted

Initial submission to the registry

February 20, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 25, 2025

Completed
9 months until next milestone

Study Start

First participant enrolled

December 8, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

December 16, 2025

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

February 20, 2025

Last Update Submit

December 8, 2025

Conditions

Keywords

Fertility preservationChild Adolescent and Young AdultsDecision AidCAYACancer Survivors

Outcome Measures

Primary Outcomes (1)

  • Unmet information needs as measured by the Unmet Information Needs Scale within 8 weeks of randomisation

    Unmet information needs will be measured within 8 weeks post-randomisation using the Unmet Information Needs Scale. Items included in the questionnaire are: knowledge regarding fertility status, future parenthood goals, and information regarding fertility preservation procedures carried out at either the treatment or survivorship period. Needs are assessed on a 6-point scale, ranging from 0 to 5, with higher scores indicating greater unmet information needs.

    within 8 weeks from randomisation

Secondary Outcomes (16)

  • Change in unmet fertility information needs as measured by questionnaire at 6 months post-randomisation

    6 months post-randomisation

  • Change in fertility knowledge as measured using a purposively designed knowledge scale within 8 weeks of randomisation and at 6 months post-randomisation

    within 8 weeks of randomisation, 6 months after randomisation

  • Change in decision making preparedness regarding fertility preservation measured by the Preparation for Decision Making Scale within 8 weeks of randomisation and at 6 months post-randomisation

    within 8 weeks of randomisation, 6 months after randomisation

  • Change in decisional conflict as measured by the a validated decisional conflict scale within 8 weeks of randomisation and at 6 months post-randomisation

    within 8 weeks and 6 months after randomisation

  • Change in feasibility and acceptability of the information resources measured using a validated feasibility and acceptability scale within 8 weeks of randomisation and at 6 months post-randomisation

    within 8 weeks of randomisation, 6 months after randomisation

  • +11 more secondary outcomes

Other Outcomes (1)

  • Changes in perceived usefulness of the information resources measured by a 5-item Decision Aid development scale at the time of diagnosis

    within 8 weeks of randomisation, 6 months after randomisation

Study Arms (2)

Decision aid group

ACTIVE COMPARATOR

Participants will have access to fertility preservation Decision Aid (DA) in addition to high-quality information (intervention group).

Other: Decision-aid

CanTeen group

NO INTERVENTION

Participants will have access to high-quality information from CanTeen website (Control group).

Interventions

Decision Aids (DA) are evidence-based clinical tools developed for patients to supplement clinicians' discussions and facilitate difficult preference-sensitive decisions. They are the gold standard approach (recommended by the Australian Commission of Safety and Quality in Healthcare) to facilitate complex healthcare decisions where there is more than one reasonable choice and where patients may value benefits and risks differently.

Decision aid group

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Be able to communicate in English.
  • Signed written informed consent form.
  • Parents/guardians of CAYA survivors who were ≤25 years (2) when diagnosed with cancer and have completed curative gonadotoxic treatment
  • CAYA cancer survivors aged 16 years or over who have completed curative gonadotoxic treatment.
  • Participants can be on long-term adjuvant or endocrine therapy.
  • Participants may have achieved a pregnancy or livebirth.

You may not qualify if:

  • CAYA patients currently undergoing cancer treatment and their parents/guardians.
  • CAYA patients who are palliative and their parents/guardians
  • A family member already in the study.
  • Minors who are not deemed to be mature minors as per protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Murdoch Children's Research Institute

Melbourne, Victoria, 3052, Australia

RECRUITING

Related Publications (4)

  • McDougall RJ, Gillam L, Delany C, Jayasinghe Y. Ethics of fertility preservation for prepubertal children: should clinicians offer procedures where efficacy is largely unproven? J Med Ethics. 2018 Jan;44(1):27-31. doi: 10.1136/medethics-2016-104042. Epub 2017 Oct 30.

  • Turcotte S, Guerrier M, Labrecque M, Robitaille H, Rivest LP, Hess B, Legare F. Dyadic validity of the Decisional Conflict Scale: common patient/physician measures of patient uncertainty were identified. J Clin Epidemiol. 2015 Aug;68(8):920-7. doi: 10.1016/j.jclinepi.2015.03.005. Epub 2015 Mar 21.

  • Lehmann V, Keim MC, Nahata L, Shultz EL, Klosky JL, Tuinman MA, Gerhardt CA. Fertility-related knowledge and reproductive goals in childhood cancer survivors: short communication. Hum Reprod. 2017 Nov 1;32(11):2250-2253. doi: 10.1093/humrep/dex297.

  • Benedict C, Stal J, Davis A, Zeidman A, Pons D, Schapira L, Diefenbach M, Ford JS. Greater fertility distress and avoidance relate to poorer decision making about family building after cancer among adolescent and young adult female survivors. Psychooncology. 2023 Oct;32(10):1606-1615. doi: 10.1002/pon.6212. Epub 2023 Sep 11.

MeSH Terms

Interventions

Decision Support Techniques

Intervention Hierarchy (Ancestors)

Investigative Techniques

Central Study Contacts

Diana Navarro-Perez, PhD

CONTACT

Yasmin Jayasinghe, FRANZCOG, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2025

First Posted

March 25, 2025

Study Start

December 8, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

December 16, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

The current protocol states that data will not be shared. The protocol will be modified in due course to include data sharing and the record will be updated to reflect this.

Locations